Pnc Financial Services »

4d Molecular Therapeutics In shares owned by Pnc Financial Services

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $891 28 31.86
2023-12-31 $648 32 20.25

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Erie Indty Cl A (ERIE)
Ishares Tr Msci Usa Qlt F (QUAL)
JPMorgan Chase & Co. (JPM)
Wisdomtree Tr Us Qtly Div Gr (DGRW)
Procter & Gamble Company (PG)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)
Exxon Mobil Corporation (XOM)
Ishares Tr Msci Intl Qual (IQLT)

View all positions for Pnc Financial Services

Top funds holding 4d Molecular Therapeutics In

RA Capital Management
VR Adviser
BlackRock
BVF
Henderson Group
Goldman Sachs Group
Viking Global Investors
Vanguard Group
Morgan Stanley
Redmile Group
Arrowpoint Asset Management
Braidwell
FMR
Geode Capital Management
Casdin Capital

View all funds holding 4d Molecular Therapeutics In